Search

Presents letters to the editor referencing articles and topics discussed in previous issues. United States President Richard Nixon's domestic policies; "There's Gold in Them There Pills," which is about abuse of the drug methaqualone published in the April 21, 1973 issue; Difference between Schedules II and III of the Controlled Substances Act of 1970.

The article presents political news briefs with commentary for the week of October 10, 1970. The administration of United States president Richard Nixon has rejected the findings of the Scranton Report that has made recommendations for handling violence and conflict on college campuses in recent years. The United States Comprehensive Drug Abuse Prevention and Control Act of 1970 has passed in both the Senate and House and will likely become law.

Focuses on efforts of the U.S. President Richard Nixon and the Attorney General for reduction in crime rate in the U.S. Proposals of the Attorney General to deal with the increasing crime rate; Discussion on expected laws and legislation for drug control; View that drug addiction under present conditions results in an insatiable need for money, and hence leads to crime; Information on the drug bill which punishes criminally the distribution or use of drugs for other than medicinal purposes; Comments on the preventive detention bill.

Presents letters to the editor referencing articles and topics discussed in previous issues. Review of Walter Goodman's book "The Committee": "Big Brother Keeps Tabs on Insurance Buyers," which described the activities of Retail Credit Co.; "Busted," which discussed a special academic or middle class immunity to drug laws.

Highlights flaws in various consumer legislation under the administration of President Lyndon Baines Johnson as of October 1965. Stand of the administration on the proposal of the Federal Trade Commission to regulate cigarette and tobacco advertising; Factors which contributed to the increase in automobile prices in the U.S.; Failure of the Food and Drug Administration to regulate the sale of cyclizine and meclizine.

Presents the results of a study conducted on cyclamate sweeteners by the Institute of Experimental Pathology and Toxicology at Albany Medical College in New York. Background of the Kefauver-Harris Drug Amendments to the Federal Food, Drug and Cosmetic Act; History of the approval of cyclamate sweeteners; Uses of cyclamates; Correlation between cyclamates and diarrhea; Danger posed by cyclamates on diet-conscious U.S. citizens.

Provides information on the proposed legislation as of March 1968, that could pin a criminal label on college students who have tried LSD in the U.S. Results of hearings completed by the House commerce subcommittee; Inconsistency of present drug laws, brought up by advocates of reducing or eliminating penalties for marijuana; Interest of the academic community in the proposed legislation.

Argues against the laws governing marijuana in the U.S. in 1967. Comment on the equation of marijuana with opiates; Difference between marijuana and opiates; Support for the medical uses of marijuana; Provisions of the Federal Narcotic Control Act of 1956; Need to address the stigmatizing impact of the laws governing marijuana on students.

Presents several correspondence on case trials and political issues. Comments on Lieutenant Colonel Herbert's side as a witness on the “Herbert Affair&rdqou; case; Concern for broadcast journalism on the May issue of The Atlantic; Aim of the pharmaceutical industry's reliance on prisoners for testing drugs.

Reveals that considerable sentiment is reported to exist on the U.S. Senate Subcommittee for altering the use of medical drugs through the imposition of more bureaucratic regulation. Remarks from Dr. Jan Koch-Weser about the role of potent drugs in life-threatening diseases; Factor that makes the manufacture and distribution of drugs to American consumers one of the most complicated and expensive procedures in the world; Good news on the cost of high-quality medicine in the U.S.